- Blood Sugar
- Clinical Studies
- Complementary Medicine
- Diabetes and Men
- Erectile Dysfunction
- Food and Nutrition
- Insulin Pumps
- Meters and Test Strips
- Product Recalls
- Type 1
- Type 2
- Weight Loss Surgery
May 22, 2013 (Beth Israel Deaconnes Medical Center) — Marijuana use among diabetic patients who admitted using marijuana is associated with improved diabetic control, say investigators. They found that current marijuana users had significantly lower fasting insulin and insulin resistance even after excluding patients with a diagnosis of diabetes mellitus. Their findings are reported in the current issue of The American Journal of Medicine.
Marijuana (Cannabis sativa) has been u
May 23, 2013 (Walter and Eliza Hall Institute of Medical Research) — Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.
The discovery has wider repercussions, as the protein is responsible for protecting the body against excessive immune responses, and could be used to treat, or even prevent, other immune d
May 23, 2013 (MIT) — Injectable nanoparticles developed at MIT may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin.
The nanoparticles were designed to sense glucose levels in the body and respond by secreting the appropriate amount of insulin, thereby replacing the function of pancreatic islet cells, which are destroyed in patients with Type 1 diabetes. Ultimately, thi
May 19, 2013 (Newswise) — Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference in Philadelphia.
"Sleep apnea, a condition associated with breathing dist
May 16, 2013 (Newswise) — A clinical trial at the University of Chicago Medicine aims to find new ways of preventing type 2 diabetes or slow its progression by treating participants with medications normally used for people who have had full-blown diabetes for at least one year. The trial will enroll individuals who are pr